PerkinElmer, Inc.
PKI
Pozycja w akcjach
#1431
PerkinElmer, Inc. operates as a global enterprise delivering innovative... PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Cena akcji
$120.30
Ostatnia synchronizacja: 2023-05-23
Kapitalizacja rynkowa
$15.17B
Zmiana (1 dzień)
0.05%
Zmiana (1 rok)
0.00%
Kraj
US
Handel PerkinElmer, Inc. (PKI)
Kategoria
Healthcare
Liczba akcji w obrocie dla PerkinElmer, Inc. (PKI)
Liczba akcji w obrocie na dzień October 2026: 0
Zgodnie z najnowszymi raportami finansowymi i ceną akcji PerkinElmer, Inc., aktualna liczba akcji w obrocie to 0. Na koniec October 2026 firma posiadała 0 akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla PerkinElmer, Inc. (PKI) od 2001 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2025 | 116.60M | -4.02% |
| 2024 | 121.47M | -3.71% |
| 2023 | 126.16M | 8.60% |
| 2022 | 116.17M | 4.17% |
| 2021 | 111.51M | 0.62% |
| 2019 | 110.83M | 0.24% |
| 2018 | 110.56M | 0.64% |
| 2017 | 109.86M | -2.36% |
| 2016 | 112.51M | -0.08% |
| 2014 | 112.59M | 0.30% |
| 2013 | 112.25M | -1.30% |
| 2012 | 113.73M | -2.89% |
| 2011 | 117.11M | 0.74% |
| 2010 | 116.25M | -1.20% |
| 2008 | 117.66M | -0.82% |
| 2007 | 118.64M | -4.76% |
| 2006 | 124.57M | -2.73% |
| 2005 | 128.06M | 1.56% |
| 2003 | 126.09M | 0.42% |
| 2002 | 125.57M | 20.09% |
| 2001 | 104.56M | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 370.00M | - |
US
|
|
| 703.80M | - |
US
|
|
| 143.28M | - |
US
|
|
| - | - |
CN
|
|
| 282.00M | - |
US
|
